Brief: Daewoong Pharma Says Signs $12 Mln Worth Deals In New Zealand, Israel, Ukraine
20/12/2018 06:52
Dec 20 (Reuters) - Daewoong Pharma 069620.KS :
* SAYS SIGNS DEAL WORTH $12 MILLION TO EXPORT ITS BOTOX
PRODUCT IN
NEW ZEALAND, ISRAEL, UKRAINE
* AIMS TO RELEASE IN 2020
Source text for Eikon: https://bit.ly/2rI1qDI
Further company coverage: 069620.KS
((Reuters Messaging: joori.roh.thomsonreuters.com@reuters.net))
Recent news on Daewoong Pharma
See all newsBrief: Daewoong Pharma Q2 Operating. Profit 77 Billion Won, Up 23% Y/Y
Brief: Daewoong Pharma Wins 92.6 Billion Won Order
Brief: Daewoong Pharma Q4 Operating Profit 45.5 Billion Won, Up 9% From Year Earlier
Brief: Daewoong Pharma Q2 Operating Profit 62.5 Billion Won, Up 26% From Year Earlier
Brief: Daewoong Pharma Q1 Operating Profit 42 Billion Won, Up 34.5% From Year Earlier